Jacobs Levy Equity Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,448
Closed -$254K 1063
2020
Q3
$254K Sell
2,448
-3,145
-56% -$316K ﹤0.01% 918
2020
Q2
$513K Sell
5,593
-17,963
-76% -$1.72M 0.01% 782
2020
Q1
$2.12M Buy
23,556
+17,283
+276% +$1.84M 0.03% 461
2019
Q4
$712K Buy
6,273
+1,553
+33% +$170K 0.01% 738
2019
Q3
$513K Sell
4,720
-44,260
-90% -$4.62M 0.01% 716
2019
Q2
$4.77M Sell
48,980
-35,230
-42% -$3.22M 0.07% 353
2019
Q1
$7.67M Buy
84,210
+58,350
+226% +$5.22M 0.11% 248
2018
Q4
$2.35M Sell
25,860
-3,410
-12% -$319K 0.04% 427
2018
Q3
$2.88M Buy
+29,270
New +$2.71M 0.04% 442
2017
Q4
Sell
-17,300
Closed -$1.34M 1036
2017
Q3
$1.34M Buy
+17,300
New +$1.44M 0.03% 526
2014
Q3
Sell
-82,540
Closed -$5.26M 878
2014
Q2
$5.26M Sell
82,540
-126,250
-60% -$7.67M 0.09% 265
2014
Q1
$12.8M Sell
208,790
-6,599
-3% -$384K 0.22% 138
2013
Q4
$12.4M Sell
215,389
-10,120
-4% -$574K 0.19% 167
2013
Q3
$12M Buy
225,509
+160,410
+246% +$8.63M 0.2% 153
2013
Q2
$3.35M Buy
+65,099
New +$3.22M 0.06% 331

Other funds holding MDT

Jacobs Levy Equity Management's MDT Position: Q4 2020 in Review

Jacobs Levy Equity Management sold out of Medtronic (MDT) in Q4 2020, closing a stake of 2,448 shares — an estimated $254K sold.

Jacobs Levy Equity Management first reported a position in MDT in Q2 2013 and held it in 15 quarters. The position peaked at $12.8M in Q1 2014. 1,957 funds tracked by Wall St. Rank hold MDT as of Q4 2020.

  • Jacobs Levy Equity Management reported no remaining Medtronic position as of Q4 2020 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 2,448 Medtronic shares in Q4 2020, an estimated $254K.
  • Jacobs Levy Equity Management first reported a position in Medtronic in Q2 2013 and held it in 15 quarters.
  • Jacobs Levy Equity Management's Medtronic position peaked at $12.8M in Q1 2014.
  • 1,957 funds tracked by Wall St. Rank held Medtronic as of Q4 2020.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2020, filed 16 Feb 2021.